 Revision chronology:      ,
. . . 2004-Jan-30:             ,Original
. . . 2004-Feb-7:             ,"Amendment 01.:
"
                                            ,Primary reason for amendment: changes in Section 7.1 regarding composition of comparator placebo
                                           ,Additional changes (these changes in and of themselves would not justify a protocol amendment): correction of typographical error in Section 3.3 . . .
. . .                                     , 
. . .  2005-Jul-25            ,"Amendment No.5:

"
 ,"At the request of US FDA [United States Food and Drug Administration] statements were added to the protocol to better clarify and define the algorithm for determining clinical or microbiological failures prior to the follow-up visit."" [33]"
